Mallory Hackett

Community by Current Health is now enrolling participants in a COVID-19 study that uses its FDA-cleared remote monitoring system.
By  Mallory Hackett 11:41 am February 16, 2021
Current Health, a remote patient monitoring platform, has launched Community, its latest initiative to build diverse longitudinal datasets for decentralized clinical trials. Using its FDA-cleared remote monitoring system, Current Health collects hospital-level data such as respiratory rate, heart rate, temperature, oxygen saturation and movement without asking the patient to leave home. The...
The back-to-work tool builds upon Masimo’s SafetyNet remote monitoring system that was developed to help hospitals care for patients in non-traditional settings.
By  Mallory Hackett 11:45 am February 15, 2021
Medical device maker Masimo is the latest company to develop a solution to help businesses, schools and other organizations reopen. Today, it announced the release of SafetyNet-OPEN, a web and mobile app solution that can screen, trace and manage users as they return to work. The back-to-work tool builds upon Masimo's SafetyNet remote monitoring system that was developed at the beginning of the...
The company attributes volume growth, new patient additions and increasing awareness of real-time continuous glucose monitoring to its revenue growth.
By  Mallory Hackett 12:02 pm February 12, 2021
Despite the challenges of 2020, Dexcom was able to close the year out with financial growth for both the fourth quarter and the full year, according to its earnings report released Thursday. In the earnings call, Dexcom’s chairman, president and CEO Kevin Sayer voiced his gratitude to the company for surpassing its goals even under the extreme circumstances last year. “In any given year, these...
The company upwardly revised its IPO twice since filing with the SEC last month.
By  Mallory Hackett 11:32 am February 11, 2021
Value-based healthcare platform Signify Health is making its debut on the New York Stock Exchange today with an initial public offering of 23,500,000 shares of its Class A common stock at $24 per share. The company upwardly revised its IPO twice since filing with the Securities and Exchange Commission last month. It originally planned to offer 23.5 million shares priced between $17 and $19, and...
With CardioCare already in its portfolio, egnite plans to develop more solutions that harness data science to improve patient outcomes and reduce healthcare costs.

Photo provided by egnite

By  Mallory Hackett 02:00 pm February 10, 2021
A new digital healthcare company called egnite launched Wednesday with the goal of leveraging advanced technologies and analytics to improve health outcomes for structural heart-disease patients. Egnite originates from the CardioCare platform developed by Edwards Lifesciences, which is already deployed at over 50 hospitals and health systems across the country. The platform is designed to manage...
Equip uses virtual family-based treatment to help children, teens and young adults overcome eating disorders.

Credit: Equip

By  Mallory Hackett 10:00 am February 10, 2021
Equip, a virtual eating disorder treatment program, has closed a Series A financing round worth $13 million led by Optum Ventures. The round also had participation from new investor .406 Ventures and existing investor F-Prime Capital, which led Equip's previous seed round. Together, the rounds bring Equip's total funding to $17 million. WHAT THEY DO Equip uses virtual family-based treatment (FBT...
Users can import their blood sugar data automatically by connecting with their LifeScan OneTouch Reveal app or by manually logging their levels.
By  Mallory Hackett 11:38 am February 8, 2021
Fitbit users can now track their blood glucose levels within the device’s connected app, the company announced Monday in a blog post. Users can import their blood sugar data automatically by connecting with their LifeScan OneTouch Reveal app or by manually logging their levels. Fitbit will be adding other glucose meters and apps in the future, it said in the announcement. Within the Fitbit app,...
The deal values 23andMe at approximately $3.5 billion through the combination of stock and cash financing.
By  Mallory Hackett 11:56 am February 4, 2021
Consumer genomics platform 23andMe is on its way to becoming a publicly-traded company through its merger with VG Acquisition Corp., a special purpose acquisition company sponsored by Virgin Group. The two companies announced today they have entered into a definitive merger agreement that is expected to close in the second quarter of this year. Once completed, the combined companies’ stock will...
The Intelligent Vaccine Impact solution promises to increase the “availability and equitable access” of vaccines while assisting governments in the distribution process.
By  Mallory Hackett 12:00 pm February 3, 2021
Google Cloud has joined the growing list of tech companies creating tools to support the national COVID-19 vaccination effort with the launch of its Intelligent Vaccine Impact solution. The tool is designed to help regional and local governments vaccinate their populations by supplying them with a central location to share vaccine information, schedule inoculation appointments, track vaccine...
The Ellume COVID-19 Home Test was the first rapid self-test authorized by the FDA for the detection of COVID-19 in individuals with or without symptoms.
By  Mallory Hackett 11:47 am February 2, 2021
The Biden administration has cut a deal with Australian digital diagnostics company Ellume to increase the availability of its at-home rapid response COVID-19 test kit in the U.S. The Department of Defense, with the Department of Health and Human Services, will pay $231.8 million for Ellume to deliver 8.5 million tests across the U.S. in accordance with the National Strategy for the COVID-19...